Emma Beausang
Consigliere Generale presso GH RESEARCH PLC
Profilo
Emma Beausang is currently working as the VP-Regulatory Affairs & Quality Assurance at GH Research Plc.
Previously, she worked as the Vice President-Regulatory Affairs at Aerie Pharmaceuticals, Inc. Dr. Beausang holds a doctorate degree from UCL School of Pharmacy and an undergraduate degree from the University of Strathclyde.
Posizioni attive di Emma Beausang
| Società | Posizione | Inizio |
|---|---|---|
| GH RESEARCH PLC | Consigliere Generale | - |
Precedenti posizioni note di Emma Beausang
| Società | Posizione | Fine |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Consigliere Generale | 01/12/2021 |
Formazione di Emma Beausang
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Emma Beausang
